Literature DB >> 18941172

Cutting edge: IFN-gamma enables APC to promote memory Th17 and abate Th1 cell development.

Ilona Kryczek1, Shuang Wei, Wenrong Gong, Xiaogong Shu, Wojciech Szeliga, Linhua Vatan, Lieping Chen, Guobin Wang, Weiping Zou.   

Abstract

Th1-derived IFN-gamma targets naive T cells and inhibits Th17 development. However, Th1, Th17, and memory but not naive T cells are colocalized in an inflammatory environment. To demonstrate the kinetic relationship between these T cell subsets, we investigated the role of IFN-gamma in regulating the development and balance between Th17 and Th1 in humans. We show that IFN-gamma stimulates B7-H1 expression on APC subsets and abates their Th1 polarization capacity in a B7-H1-dependent manner. Interestingly, IFN-gamma triggers APCs to produce IL-1 and IL-23 and enables them to induce memory Th17 expansion via IL-1 and IL-23 in a B7-H1-independent manner. We propose a novel dynamic between Th1 and Th17 in the course of inflammation as follows: Th1-mediated inflammation is attenuated by IFN-gamma-induced B7-H1 on APCs and is evolved toward Th17-mediated chronic inflammation by IFN-gamma-induced, APC-derived IL-1 and IL-23. Our study challenges the dogma that IFN-gamma suppresses Th17 and enhances Th1 development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18941172     DOI: 10.4049/jimmunol.181.9.5842

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

Review 1.  Induction of Th17 cellular immunity with a novel nanoemulsion adjuvant.

Authors:  Anna U Bielinska; Michele Gerber; Luz P Blanco; Paul E Makidon; Katarzyna W Janczak; Michael Beer; Benjamin Swanson; James R Baker
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

Review 2.  T(H)17 cells in tumour immunity and immunotherapy.

Authors:  Weiping Zou; Nicholas P Restifo
Journal:  Nat Rev Immunol       Date:  2010-04       Impact factor: 53.106

Review 3.  Plasticity of T-cell phenotype and function: the T helper type 17 example.

Authors:  Ariana Peck; Elizabeth D Mellins
Journal:  Immunology       Date:  2009-11-17       Impact factor: 7.397

Review 4.  Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease.

Authors:  Zhan-Ju Liu; Praveen-K Yadav; Jing-Ling Su; Jun-Shan Wang; Ke Fei
Journal:  World J Gastroenterol       Date:  2009-12-14       Impact factor: 5.742

5.  Th17 cell expansion in gastric cancer may contribute to cancer development and metastasis.

Authors:  Zhaoliang Su; Yingkun Sun; Haitao Zhu; Yueqin Liu; Xin Lin; Huiling Shen; Jianguo Chen; Wenlin Xu; Huaxi Xu
Journal:  Immunol Res       Date:  2014-01       Impact factor: 2.829

Review 6.  Clinical blockade of PD1 and LAG3--potential mechanisms of action.

Authors:  Linh T Nguyen; Pamela S Ohashi
Journal:  Nat Rev Immunol       Date:  2015-01       Impact factor: 53.106

7.  Potentially pathogenic immune cells and networks in apparently healthy lacrimal glands.

Authors:  Austin K Mircheff; Yanru Wang; Chuanqing Ding; Dwight W Warren; Joel E Schechter
Journal:  Ocul Surf       Date:  2014-11-06       Impact factor: 5.033

Review 8.  Inducible expression of B7-H1 (PD-L1) and its selective role in tumor site immune modulation.

Authors:  Miguel F Sanmamed; Lieping Chen
Journal:  Cancer J       Date:  2014 Jul-Aug       Impact factor: 3.360

9.  Down-regulation of UL16-binding protein 3 mediated by interferon-gamma impairs immune killing in nasopharyngeal carcinoma.

Authors:  Lingling Guo; Yu Chen; Jing Wang; Chuanben Chen
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

Review 10.  PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations.

Authors:  Weiping Zou; Jedd D Wolchok; Lieping Chen
Journal:  Sci Transl Med       Date:  2016-03-02       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.